Recombinant Human ErbB2/Her2 Protein | RP02057

Product Overview:

Recombinant Human CD39 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Thr23-Thr652) of human ErbB2/Her2 (Accession #P04626) fused with a 6xHis, Avi tag at the C-terminus.

Bioactivity:

Immobilized Human Her2 at 0.2ug/mL (100uL/well), dose response curve for Anti-Her2 Ab Trastuzumab with the EC₅₀ of 17.4ng/mL determined by ELISA.

Source:

Human

Shipping Conditions:

Ice Bag